Comparison of 2 Ventilatory Support Strategies During Coronavirus Disease 2019 (Covid-19) Pneumonia

Comparison of 2 Ventilatory Support Strategies in Patients With Covid-19 Pneumonia Admitted in ICU : Retrospective Monocentric Study

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04799691

Acronym

STRATIC

Enrollment

133

Registered

2021-03-16

Start date

2021-02-01

Completion date

2022-01-15

Last updated

2022-10-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Keywords

Invasive strategy, Non-invasive strategy, Continuous Positive Airway Pressure, High Flow Nasal Canula, Prone position

Brief summary

This retrospective monocentric study compares 2 ventilatory support strategies on outcomes (length of stay, intubation, mortality) in patients admitted in Intensive Care Unit with Covid-19 related pneumonia : invasive strategy used during the first period and non-invasive strategies (Continuous Positive Airway Pressure, High Flow Nasal Canula, Prone Position) used during the second period.

Interventions

PROCEDUREInvasive ventilation strategy

Use of an invasive ventilatory support strategy

PROCEDURENon-invasive ventilation strategies

Use of non-invasive ventilatory support strategies

Study design

Observational model

CASE_CONTROL

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patient with confirmed SARS COV2 infection * Acute Respiratory Distress Syndrome * Patient more than 18 year old

Exclusion criteria

* Intensive Care Unit admission for extra pulmonary failure * Do Not Reanimated order * Patient from another Intensive Care Unit * Patient objection * Judicial protection

Design outcomes

Primary

Measure	Time frame	Description
Length of stay in ICU	At the moment of ICU discharge or death, up to 3 month	Number of days spent in ICU

Secondary

Measure	Time frame	Description
Mortality	At the moment of ICU discharge or death, up to 3 month	Rate of patients alive at the moment of intensive care unit discharge
Complications	At the moment of ICU discharge or death, up to 3 month	Number of complications during intensive care unit stay

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026